244 related articles for article (PubMed ID: 23544132)
1. Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.
Kalani A; Mohan A; Godbole MM; Bhatia E; Gupta A; Sharma RK; Tiwari S
PLoS One; 2013; 8(3):e60177. PubMed ID: 23544132
[TBL] [Abstract][Full Text] [Related]
2. Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.
Abe H; Sakurai A; Ono H; Hayashi S; Yoshimoto S; Ochi A; Ueda S; Nishimura K; Shibata E; Tamaki M; Kishi F; Kishi S; Murakami T; Nagai K; Doi T
J Med Invest; 2018; 65(3.4):208-215. PubMed ID: 30282862
[TBL] [Abstract][Full Text] [Related]
3. New-onset diabetes after kidney transplantation: Assessing urinary Wilm's tumor-1 protein to predict renal allograft dysfunction.
de Andrade CES; Souza KSC; Galdino OA; de Lima MAF; de Medeiros PJ; Abbott Galvão Ururahy M; Pereira MG; de Almeida JB; de Rezende AA
Adv Med Sci; 2024 Mar; 69(1):153-159. PubMed ID: 38490331
[TBL] [Abstract][Full Text] [Related]
4. Urinary exosomal WT1 in childhood nephrotic syndrome.
Lee H; Han KH; Lee SE; Kim SH; Kang HG; Cheong HI
Pediatr Nephrol; 2012 Feb; 27(2):317-20. PubMed ID: 22076591
[TBL] [Abstract][Full Text] [Related]
5. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
[TBL] [Abstract][Full Text] [Related]
6. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.
Sakurai A; Ono H; Ochi A; Matsuura M; Yoshimoto S; Kishi S; Murakami T; Tominaga T; Nagai K; Abe H; Doi T
PLoS One; 2019; 14(5):e0216788. PubMed ID: 31150422
[TBL] [Abstract][Full Text] [Related]
8. Urine exosomal ceruloplasmin: a potential early biomarker of underlying kidney disease.
Gudehithlu KP; Hart P; Joshi A; Garcia-Gomez I; Cimbaluk DJ; Dunea G; Arruda JAL; Singh AK
Clin Exp Nephrol; 2019 Aug; 23(8):1013-1021. PubMed ID: 30955187
[TBL] [Abstract][Full Text] [Related]
9. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of subnormal glomerular filtration rate in patients with diabetes mellitus].
Trofimenko II; Dobronravov VA; Bystrova NN; Drozdova IuV; Galkina OV; Smirnov AV
Ter Arkh; 2008; 80(6):48-52. PubMed ID: 18655476
[TBL] [Abstract][Full Text] [Related]
11. Urinary biomarkers in obstructive nephropathy.
Trnka P; Ivanova L; Hiatt MJ; Matsell DG
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1567-75. PubMed ID: 22859744
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy.
Zelmanovitz T; Gross JL; Oliveira J; de Azevedo MJ
Diabetes Care; 1998 Jul; 21(7):1076-9. PubMed ID: 9653598
[TBL] [Abstract][Full Text] [Related]
13. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
14. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy.
Zhang W; Ren Y; Li J
Ren Fail; 2019 Nov; 41(1):704-717. PubMed ID: 31352863
[No Abstract] [Full Text] [Related]
15. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.
Yu Y; Bai F; Qin N; Liu W; Sun Q; Zhou Y; Yang J
Nephron; 2018; 139(3):269-282. PubMed ID: 29539618
[TBL] [Abstract][Full Text] [Related]
16. Levels and Clinical Significances of Glypican-5 in Urine of Type 2 Diabetic Nephropathy Cases.
Li R; Zhang L; Zhang S; Yang H; Yao B; Dong W; Zhang B; Chen Y; Liu S; Zhao X; Zhang Q; Shi W; Liang X
Iran J Kidney Dis; 2019 May; 13(3):173-181. PubMed ID: 31209190
[TBL] [Abstract][Full Text] [Related]
17. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
Kitai Y; Doi Y; Osaki K; Sugioka S; Koshikawa M; Sugawara A
Clin Exp Nephrol; 2015 Dec; 19(6):1037-43. PubMed ID: 25680889
[TBL] [Abstract][Full Text] [Related]
18. Urinary exosomal transcription factors, a new class of biomarkers for renal disease.
Zhou H; Cheruvanky A; Hu X; Matsumoto T; Hiramatsu N; Cho ME; Berger A; Leelahavanichkul A; Doi K; Chawla LS; Illei GG; Kopp JB; Balow JE; Austin HA; Yuen PS; Star RA
Kidney Int; 2008 Sep; 74(5):613-21. PubMed ID: 18509321
[TBL] [Abstract][Full Text] [Related]
19. WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy.
Hashemi E; Dehghanbanadaki H; Baharanchi AA; Forouzanfar K; Kakaei A; Mohammadi SM; Zeidi S; Razi F
J Transl Med; 2021 Jul; 19(1):299. PubMed ID: 34246281
[TBL] [Abstract][Full Text] [Related]
20. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
